UFP Technologies Announces Record 2025 Results

NEWBURYPORT, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported 2025 net income of $68.3 million, 15.8% higher than net income of $59.0 million for 2024. Adjusted net income grew 12.7% to $76.1 million. Net sales for the year ended December 31, 2025 were $602.8 million, 19.5% higher than 2024 sales of $504.4 million. GAAP and adjusted earnings per diluted common share outstanding (“EPS”) for the year ended December 31, 2025 were $8.75 and $9.76, respectively.

GlobeNewsWire • 3 hours ago

UFP Technologies to Report Fourth Quarter and Year-End 2025 Financial Results on February 24, 2026

NEWBURYPORT, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that the Company plans to report results for the fourth quarter and year-end on Tuesday, February 24th, after the close of the stock market.

GlobeNewsWire • Feb 19, 2026

This Small-Cap Gem Could Be the Next 10-Bagger

This medtech stock has already been a 12-bagger over the past decade. It has built a leading position in its niche, helped in part by tuck-in acquisitions.

The Motley Fool • Jan 21, 2026

MoneyShow's Best Investment Ideas For 2026: Part 9

MoneyShow presents top investment ideas for 2026 from their contributors. This year's edition presents a mix of metals plays, financial stocks, deep value names, high-octane growth and tech stocks, and beaten-down REITs that offer solid income and turnaround potential. Part 9 of this series includes Target Corp., The Trade Desk, UFP Technologies, Verizon, and Williams Companies.

Seeking Alpha • Jan 21, 2026

These 3 Small-Cap Stocks Are Built to Weather a Slowdown

The Russell 2000 index, commonly referred to as the “small-cap index,” has increased by approximately 6% over the past three months. This rise is mainly driven by changes in interest rates, as the Federal Reserve reduced interest rates by 75 basis points (0.75%) during this period.

MarketBeat • Jan 12, 2026

UFP Technologies Announces CEO Succession Plan

NEWBURYPORT, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that R.

GlobeNewsWire • Dec 2, 2025

UFP Technologies to Present and Host 1X1 Investor Meetings at the Piper Sandler 37th Annual Healthcare Conference

NEWBURYPORT, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly, President Mitchell C. Rock, and Chief Financial Officer Ron Lataille will participate in the upcoming Piper Sandler 37th Annual Healthcare Conference to be held in New York City December 1-4, 2025. UFP's presentation is scheduled to begin at 8:10 AM on Wednesday, December 3rd. A live audio webcast of UFP's presentation will be available here.

GlobeNewsWire • Nov 25, 2025

UFP Technologies, Inc. (UFPT) Q3 2025 Earnings Call Transcript

UFP Technologies, Inc. ( UFPT ) Q3 2025 Earnings Call November 4, 2025 8:30 AM EST Company Participants Ronald Lataille - CFO, Senior VP & Treasurer R. Bailly - CEO & Chairman Conference Call Participants Justin Ages - CJS Securities, Inc. Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Maxwell Michaelis - Lake Street Capital Markets, LLC, Research Division Noah Lewis - Raymond James & Associates, Inc., Research Division Presentation Operator Good day, and welcome to the UFP Technologies Third Quarter 2025 Earnings Conference Call.

Seeking Alpha • Nov 4, 2025

UFP Technologies Announces Strong Q3 2025 Results

NEWBURYPORT, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $16.4 million or $2.11 per diluted common share outstanding for its third quarter ended September 30, 2025, the same as in Q3 of 2024. Adjusted earnings per diluted share outstanding for the third quarter ended September 30, 2025, was $2.39. Sales for the third quarter were $154.6 million compared to sales of $145.2 million in the third quarter of 2024. Net income for the nine-month period ended September 30, 2025, was $50.7 million or $6.52 per diluted common share outstanding compared to net income of $42.6 million or $5.49 per diluted common share outstanding for the same period in 2024. Sales for the nine-month period ended September 30, 2025, were $453.9 million compared to sales of $360.4 million for the same period in 2024. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted gross margin, adjusted operating income, adjusted SG&A, adjusted net income and EPS, and EBITDA and adjusted EBITDA. Please see “Non-GAAP Financial Information” at the end of this news release.

GlobeNewsWire • Nov 3, 2025

UFP Technologies (UFPT) Beats Q3 Earnings and Revenue Estimates

UFP Technologies (UFPT) came out with quarterly earnings of $2.39 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to earnings of $2.39 per share a year ago.

Zacks Investment Research • Nov 4, 2025